133 related articles for article (PubMed ID: 30257047)
1. An efficient MRI agent targeting extracellular markers in prostate adenocarcinoma.
Pagoto A; Tripepi M; Stefania R; Lanzardo S; Livio Longo D; Garello F; Porpiglia F; Manfredi M; Aime S; Terreno E
Magn Reson Med; 2019 Mar; 81(3):1935-1946. PubMed ID: 30257047
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of High Relaxivity Gadolinium AAZTA Tetramers as Building Blocks for Bioconjugation.
Tripepi M; Capuana F; Gianolio E; Kock FVC; Pagoto A; Stefania R; Digilio G; Aime S
Bioconjug Chem; 2018 Apr; 29(4):1428-1437. PubMed ID: 29470084
[TBL] [Abstract][Full Text] [Related]
3. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.
Zhou Z; Wu X; Kresak A; Griswold M; Lu ZR
Biomaterials; 2013 Oct; 34(31):7683-93. PubMed ID: 23863450
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer.
Li Y; Han Z; Roelle S; DeSanto A; Sabatelle R; Schur R; Lu ZR
Mol Pharm; 2017 Nov; 14(11):3906-3915. PubMed ID: 28976766
[TBL] [Abstract][Full Text] [Related]
5. B25716/1: a novel albumin-binding Gd-AAZTA MRI contrast agent with improved properties in tumor imaging.
Gianolio E; Cabella C; Colombo Serra S; Valbusa G; Arena F; Maiocchi A; Miragoli L; Tedoldi F; Uggeri F; Visigalli M; Bardini P; Aime S
J Biol Inorg Chem; 2014 Jun; 19(4-5):715-26. PubMed ID: 24510295
[TBL] [Abstract][Full Text] [Related]
6. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.
Tan M; Burden-Gulley SM; Li W; Wu X; Lindner D; Brady-Kalnay SM; Gulani V; Lu ZR
Pharm Res; 2012 Apr; 29(4):953-60. PubMed ID: 22139536
[TBL] [Abstract][Full Text] [Related]
7. Peptide targeted high-resolution molecular imaging of prostate cancer with MRI.
Wu X; Yu G; Lindner D; Brady-Kalnay SM; Zhang Q; Lu ZR
Am J Nucl Med Mol Imaging; 2014; 4(6):525-36. PubMed ID: 25250202
[TBL] [Abstract][Full Text] [Related]
8. AAZTA-based bifunctional chelating agents for the synthesis of multimeric/dendrimeric MRI contrast agents.
Gugliotta G; Botta M; Tei L
Org Biomol Chem; 2010 Oct; 8(20):4569-74. PubMed ID: 20740241
[TBL] [Abstract][Full Text] [Related]
9. A new ditopic Gd(III) complex functionalized with an adamantyl moiety as a versatile building block for the preparation of supramolecular assemblies.
Gambino G; De Pinto S; Tei L; Cassino C; Arena F; Gianolio E; Botta M
J Biol Inorg Chem; 2014 Feb; 19(2):133-43. PubMed ID: 24100595
[TBL] [Abstract][Full Text] [Related]
10. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
[TBL] [Abstract][Full Text] [Related]
11. MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent.
Zhou Z; Qutaish M; Han Z; Schur RM; Liu Y; Wilson DL; Lu ZR
Nat Commun; 2015 Aug; 6():7984. PubMed ID: 26264658
[TBL] [Abstract][Full Text] [Related]
12. [Gd(AAZTA)]
Kock FVC; Forgács A; Guidolin N; Stefania R; Vágner A; Gianolio E; Aime S; Baranyai Z
Chemistry; 2021 Jan; 27(5):1849-1859. PubMed ID: 33184913
[TBL] [Abstract][Full Text] [Related]
13. A Bioinspired Nanoprobe with Multilevel Responsive T
Li Y; Zhao X; Liu X; Cheng K; Han X; Zhang Y; Min H; Liu G; Xu J; Shi J; Qin H; Fan H; Ren L; Nie G
Adv Mater; 2020 Jan; 32(4):e1906799. PubMed ID: 31799765
[TBL] [Abstract][Full Text] [Related]
14. Gd-AAZTA-MADEC, an improved blood pool agent for DCE-MRI studies on mice on 1 T scanners.
Longo DL; Arena F; Consolino L; Minazzi P; Geninatti-Crich S; Giovenzana GB; Aime S
Biomaterials; 2016 Jan; 75():47-57. PubMed ID: 26480471
[TBL] [Abstract][Full Text] [Related]
15. In Vivo MR Imaging of Fibrin in a Neuroblastoma Tumor Model by Means of a Targeting Gd-Containing Peptide.
Chaabane L; Tei L; Miragoli L; Lattuada L; von Wronski M; Uggeri F; Lorusso V; Aime S
Mol Imaging Biol; 2015 Dec; 17(6):819-28. PubMed ID: 25875866
[TBL] [Abstract][Full Text] [Related]
16. Magnetic-optical dual-modality imaging monitoring chemotherapy efficacy of pancreatic ductal adenocarcinoma with a low-dose fibronectin-targeting Gd-based contrast agent.
Zhang W; Liang X; Zhang X; Tong W; Shi G; Guo H; Jin Z; Tian J; Du Y; Xue H
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1841-1855. PubMed ID: 38372766
[TBL] [Abstract][Full Text] [Related]
17. A multimeric MRI contrast agent based on a closo-borane scaffold bearing modified AAZTA chelates on the periphery.
Chakravarty S; Sarma SJ; Goswami LN; Cai QY; Shapiro EM; Hawthorne MF; Ma L
Chem Commun (Camb); 2019 Oct; 55(82):12348-12351. PubMed ID: 31559401
[TBL] [Abstract][Full Text] [Related]
18. Generation of multiparametric MRI maps by using Gd-labelled- RBCs reveals phenotypes and stages of murine prostate cancer.
Ferrauto G; Di Gregorio E; Lanzardo S; Ciolli L; Iezzi M; Aime S
Sci Rep; 2018 Jul; 8(1):10567. PubMed ID: 30002426
[TBL] [Abstract][Full Text] [Related]
19. Fast and easy access to efficient bifunctional chelators for MRI applications.
Gugliotta G; Botta M; Giovenzana GB; Tei L
Bioorg Med Chem Lett; 2009 Jul; 19(13):3442-4. PubMed ID: 19477128
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
